Safety and Pharmacokinetics of AVL-292 Following Multiple Doses and the Effect of Food on the Single-dose Pharmacokinetics of AVL-292

NCT01692184 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: 50 mg AVL-292
DRUG: 100 mg AVL-292
DRUG: 200 mg AVL-292
DRUG: 350 mg AVL-292
DRUG: Placebo capsules

Sponsor

Celgene